QingSong Health Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	8,177	14,147	-	-	-
Enterprise Value	7,115	15,484	-	-	-
Last Close Price	39.62	68.55	-	-	-
PS Ratio	5.85	10.12	-	-	-
PB Ratio	7.33	12.69	-	-	-
P/TBV Ratio	7.48	12.94	-	-	-
P/FCF Ratio	90.30	156.23	-	-	-
P/OCF Ratio	89.51	154.87	-	-	-
EV/Sales Ratio	5.09	11.08	-	-	-
EV/EBITDA Ratio	82.07	188.16	-	-	-
EV/EBIT Ratio	86.96	189.25	-	-	-
EV/FCF Ratio	78.58	170.99	-	-	-
Debt / Equity Ratio	0.00	0.00	-1.44	-1.41	-1.30
Debt / EBITDA Ratio	0.04	0.04	27.23	11.46	10.57
Debt / FCF Ratio	0.04	0.04	21.18	220.56	28.13
Net Debt / Equity Ratio	-0.95	-0.95	-1.14	-1.14	-1.06
Net Debt / EBITDA Ratio	-12.90	-12.90	23.30	9.56	8.94
Net Debt / FCF Ratio	-11.72	-11.72	16.80	178.54	22.96
Asset Turnover	1.34	1.34	1.35	0.74	-
Quick Ratio	5.95	5.95	0.27	0.27	0.22
Current Ratio	6.36	6.36	0.31	0.32	0.32
Return on Assets (ROA)	4.89%	4.89%	5.33%	13.53%	-
Return on Invested Capital (ROIC)	151.51%	66.52%	34.89%	110.06%	-289.62%
Return on Capital Employed (ROCE)	7.30%	7.30%	-4.90%	-12.00%	-11.90%
Earnings Yield	-5.17%	-2.99%	-	-	-
FCF Yield	1.11%	0.64%	-	-	-
Buyback Yield / Dilution	17.96%	17.96%	50.09%	-152.68%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.